These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 4602675)
1. Trial of placebo in long-term chlorpropamide-treated diabetics. Lev-Ran A Diabetologia; 1974 Jun; 10(3):197-200. PubMed ID: 4602675 [No Abstract] [Full Text] [Related]
2. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas. Göschke H; Denes A; Girard J; Collard F; Berger W Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576 [No Abstract] [Full Text] [Related]
3. The effects of long-term therapy with oral hypoglycemic agents on the oral glucose tolerance test dynamics in male chemical diabetics. Tan MH; Graham CA; Bradley RF; Gleason RE; Soeldner JS Diabetes; 1977 Jun; 26(6):561-70. PubMed ID: 324835 [TBL] [Abstract][Full Text] [Related]
4. Effect of chlorpropamide treatment on insulin secretion in diabetics: its relationship to the hypoglycemic effect. Hecht A; Gershberg H; Hulse M Metabolism; 1973 May; 22(5):723-33. PubMed ID: 4704717 [No Abstract] [Full Text] [Related]
5. Treatment of the obese diabetic. A comparative study of placebo, sulfonylurea and phenformin. Abramson E; Arky RA Metabolism; 1967 Mar; 16(3):204-12. PubMed ID: 5336062 [No Abstract] [Full Text] [Related]
6. A clinical pharmacologic comparison of glyhexamide, tolbutamide and chlorpropamide in the treatment of stable diabetes. Grinnell EH; Skillman TG; Brooks AM Am J Med Sci; 1967 Mar; 253(3):312-20. PubMed ID: 5336725 [No Abstract] [Full Text] [Related]
7. Longitudinal study of untreated chemical diabetes. Logie AW; Stowers JM; Dingwall-Fordyce I Br Med J; 1974 Dec; 4(5945):630-2. PubMed ID: 4613418 [TBL] [Abstract][Full Text] [Related]
8. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose. Barnes AJ; Garbien KJ; Crowley MF; Bloom A Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696 [No Abstract] [Full Text] [Related]
10. Treatment of chemical diabetes mellitus with sulfonylurea compounds. Fajans SS Metabolism; 1973 Feb; 22(2):373-6. PubMed ID: 4687964 [No Abstract] [Full Text] [Related]
11. [Chlorpropamide-metformin in obese diabetics or diabetics with side effects from sulfonylureas. 2-year results]. Garcia Viveros M; Prado Vega R; Rull JA; Lozano-Castañeda O Prensa Med Mex; 1971; 36(7):347-9. PubMed ID: 5096256 [No Abstract] [Full Text] [Related]
12. Effects of long term sulfonylurea therapy on plasma insulin and fasting lipid levels. Podolsky S; Burney SW Diabete Metab; 1979 Jun; 5(2):113-7. PubMed ID: 478080 [TBL] [Abstract][Full Text] [Related]
13. Oral management of uncomplicated maturity onset diabetes. Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809 [No Abstract] [Full Text] [Related]
14. Impaired effect of sulfonylurea following increased dosage. Wåhlin-Boll E; Sartor G; Melander A; Scherstén B Eur J Clin Pharmacol; 1982; 22(1):21-5. PubMed ID: 7047168 [TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of a new sulfonylurea in maturity onset diabetes - glipizide (K-4024). Bandisode MS; Boshell BR Horm Metab Res; 1976 Mar; 8(2):89-91. PubMed ID: 770300 [TBL] [Abstract][Full Text] [Related]
16. [Plasma insulin and glucose levels in diabetics treated with glibenclamide and chlorporpamide]. Aiello C; Turner D; Aparicio NJ; De Turner EA; Vazquez A Acta Diabetol Lat; 1973; 10(1):30-53. PubMed ID: 4197367 [No Abstract] [Full Text] [Related]
17. The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy. Chu PC; Conway MJ; Krouse HA; Goodner CJ Ann Intern Med; 1968 Apr; 68(4):757-69. PubMed ID: 4868334 [No Abstract] [Full Text] [Related]
18. Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus. Reaven G; Dray J Diabetes; 1967 Jul; 16(7):487-92. PubMed ID: 6028757 [No Abstract] [Full Text] [Related]